Surgical extent, tumor size, and calcitonin levels in medullary thyroid carcinoma: impact on oncologic outcomes in a retrospective cohort study
Ekin Yiğit Köroğlu, Berna Evranos Öğmen, Muzaffer Serdar Deniz, Barış Saylam, Hilal Ahsen, Cevdet Aydin, Oya Topaloğlu, Reyhan Ersoy, Bekir Çakir · 2026
Read Surgical extent, tumor size, and calcitonin levels in medullary thyroid carcinoma: impact on oncologic outcomes in a retrospective cohort study by Ekin Yiğit Köroğlu, Berna Evranos Öğmen, Muzaffer Serdar Deniz, Barış Saylam, Hilal Ahsen, Cevdet Aydin, Oya Topaloğlu, Reyhan Ersoy, Bekir Çakir (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13377842.txt.
Description
Ekin Yiğit Köroğlu and others test whether surgery extent, tumour size, and that hormone predict results in that type thyroid cancer in a 2026 study. Rules base surgery mainly on that hormone levels, yet the cost of straying from rules was not fully known. Ninety-one patients with proved medullary thyroid cancer treated at a large centre from 2019 to 2025 were reviewed.
Operations were classed as concordant, less wide, or more extensive against ATA, ESMO, and NCCN guidelines. Outcomes included persistent disease within six months, recurrence after excellent response, reoperation, and problems. The study weighs tumour size, calcitonin, and surgical extent together, asking whether individualised surgery compromises results or whether guideline follow-through matters less than tumour biology.
Catalog record
| CREATOR | Ekin Yiğit Köroğlu, Berna Evranos Öğmen, Muzaffer Serdar Deniz, Barış Saylam, Hilal Ahsen, Cevdet Aydin, Oya Topaloğlu, Reyhan Ersoy, Bekir Çakir |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |